Systemic therapy for treating locoregional recurrence in women with breast cancer.

Author: ClarkeM, GatzemeierW, RauscheckerH, RechtA

Paper Details 
Original Abstract of the Article :
Between 10% and 35% of women with operable breast cancer will experience an isolated locoregional recurrence following their primary treatment. There is currently no good evidence that adjuvant systemic treatment is effective in this situation and there is no standard treatment for women who have su...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127534/

データ提供:米国国立医学図書館(NLM)

Systemic Therapy for Locoregional Recurrence in Breast Cancer

Breast cancer is a challenging disease, and even after successful primary treatment, a significant proportion of patients may experience a locoregional recurrence. It's like a desert that seems to be conquered, only to find that new sandstorms emerge. This study explores the effectiveness of adjuvant systemic treatment for women with breast cancer who have experienced a locoregional recurrence. Unfortunately, the study found that there is currently no good evidence supporting the effectiveness of this approach.

A Need for Further Research

The study concluded that there is no standard treatment for women who experience locoregional recurrence after breast cancer treatment. This highlights a gap in our knowledge and the need for further research to develop effective treatment strategies for this specific patient population. It's like searching for a new oasis in a vast and unexplored desert.

A Journey of Discovery

This research underscores the ongoing challenge of treating breast cancer and the need for continued research to develop effective strategies for managing recurrence. It's a journey of discovery in the desert, searching for better ways to combat this disease and improve the lives of patients.

Dr.Camel's Conclusion

This study highlights the ongoing need for research to develop effective treatment strategies for women with breast cancer who experience locoregional recurrence. It's a reminder that the fight against cancer is a continuous journey, requiring ongoing exploration and innovation to find new solutions.

Date :
  1. Date Completed 2002-04-19
  2. Date Revised 2021-05-19
Further Info :

Pubmed ID

11687148

DOI: Digital Object Identifier

PMC8127534

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.